All News

Scientific collaboration with Janssen Pharmaceuticals could reveal solutions to block the progression of diseases like Alzheimer's.

Donald J. Trump was elected president of the United States on November 9, 2016, defeating the predicted favorite Hillary Clinton. Here is a recap of AJMC’s coverage of the 2 candidates and their healthcare positions in the months leading up to this historic election.

A study published in the Journal of the National Comprehensive Cancer Network has found that screening for distress tests improves provider confidence and awareness toward person-centered care.

By a large margin, voters in Colorado defeated a proposal to replace the Affordable Care Act with a single-payer system in the state.

Three of the 4 cities to pass taxes on soda are in Northern California, not far from Berkeley, which passed the nation's first soda tax in 2014.

As the Republicans retained control of both the House and the Senate and Donald J. Trump was declared the next president of the United States, it became abundantly clear that President Barack Obama’s landmark healthcare reform legislation was in grave danger.

This Election Day, voters chose to legalize or expand medical marijuana in Arkansas, Florida, Montana, and North Dakota-every state where such a measure appeared on the ballot. Medical marijuana is now legal in 28 states and the District of Columbia.

What we’re reading, November 9, 2016: pharma stocks surge following US election news; Mylan will face an FTC probe over anticompetitive practices with the EpiPen; and Walgreens has filed a lawsuit against its former laboratory testing partner, Theranos.

The Prevent Cancer Foundation has developed a digital tool that can compare coverage of screening tests for breast, cervical, colorectal, lung, and prostate cancers across health insurance plans available in a specific state.

Medicaid programs throughout the country cover tobacco cessation therapies, but utilization of these benefits tends to be low and varies among states, according to a study published in the CDC’s Preventing Chronic Disease.

Patients often try, and fail, on medications before settling on one that works for anxiety or depression. A new test can help physicians select the correct medication the first time.

The FDA commissioner and the acting administrator of CMS have published an opinion piece in JAMA that recommends changes with trial design, data collection, and the need for collaboration across public and private sectors.

What we're reading, November 8, 2016: the US may not have a doctor shortage, it may just have an inefficient health system; there is a gap between the richest and poorest countries when it comes to spending on essential medicines; and scientists start another Zika virus vaccine test.

The findings come as epidemiologists have noted rising rates of liver cancer amid falling rates of cancer generally.

A spokesman for The Obesity Society said that lack of payer coverage for obesity may discourage physicians from recording body mass index and making a formal diagnosis.

Based on a retrospective meta-analysis of clinical trial data, authors of a recent paper in JAMA Oncology concluded that BRAF/MEK and programmed death receptor-1 (PD-1) inhibitors were the most effective treatments that were relatively safe in melanoma.

Patient-centered medical homes may improve the performance of process measures of care for patients with type 2 diabetes, including glycated hemoglobin tests, cholesterol tests, foot examination, dilated eye examination, flu vaccination, and adherence to oral hypoglycemic agents during 1 year of follow-up.

A new study by researchers at the Johns Hopkins University has found that second opinions did not change treatment choice among men diagnosed with low-risk prostate cancer.

What we’re reading, November 7, 2016: caretaker fraud within Medicaid’s Personal Care Services program left patients neglected and abused; a proposal to increase shift limits for first-year residents from 16 to 28 hours draws both support and criticism; CDC has identified 13 locally-acquired cases of antibiotic-resistant Candida auris in the US.

A healthcare economist explains that not all experiments with new payment models need to succeed, because failure can show the system what not to do.

Low rates of vaccination among US adults result in preventable diseases and costs to individuals and society in terms of deaths, disabilities, and economic losses from hospitalizations, lost income, and physician visits.

Treating surgical complications with the best quality care while minimizing costs remains a major challenge for hospitals. Especially when dealing with perioperative complications, hospitals have no unanimous standards for cost and care.

Within the past 3 years, hospital employment and hospital ownership of physician practices has increased in both urban and rural areas, but growth in the number of rural practices owned by hospitals has significantly outpaced that in the urban setting.

As the healthcare industry continues its transition towards alternative payment models (APMs), some providers might feel apprehensive about keeping up with new requirements like those in the Medicare Access and CHIP Reauthorization Act (MACRA) final rule. However, these providers can use healthcare information technology (IT), data analysis tools, and other resources to adapt to these changes, according to Suzanne Travis, vice president of regulatory strategy at McKesson.

Researchers from Canada’s McGill University have developed a potential tool that can detect early signs of cachexia in cancer patients, which could impact survival.

Last month, the healthcare payment network InstaMed announced that it was the first in the industry to achieve point-to-point encryption (P2PE) v2.0 validation. How important is this level of encryption for healthcare? What will this mean for those who seek better protection of their payment card data?

This week, the top stories in managed care included the new Physicians' Fee Schedule released by CMS, a focus on a ballot question in California regarding drug spending, and Patient-Centered Oncology Care announced keynote speaker Roy Beveridge, MD.

Prices rising for the same drug across multiple pharmaceutical companies might be the result of collusion, according to a letter sent to the Department of Justice and the Federal Trade Commission from Senator Bernie Sanders, I-Vermont, and Representative Elijah Cummings, D-Maryland.

Audits, consumer education, and help for states were among the recommendations to force better compliance with the 2008 law, which seeks to ensure that coverage for mental health or substance abuse disorders mirrors other benefits in a health plan.

The study identifies a potential drug target to treat diabetes.